Alliancebernstein L.P. Has $501.29 Million Holdings in Astera Labs, Inc. $ALAB

Key Points

• Alliancebernstein L.P. has increased its stake in Astera Labs, acquiring 4,478,741 shares to reach a total of 8,401,019 shares, valued at approximately $501 million.
• Astera Labs received several positive analyst ratings, with price targets ranging from $100 to $200, indicating a strong market sentiment for the company's growth potential.
• Insider selling was reported, with CEO Jitendra Mohan and CFO Michael Truett Tate selling large amounts of stock, indicating a 25% and 16% decrease in their respective ownership stakes.

Alliancebernstein L.P. grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 114.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,401,019 shares of the company's stock after buying an additional 4,478,741 shares during the quarter. Alliancebernstein L.P. owned approximately 5.09% of Astera Labs worth $501,289,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Gen Wealth Partners Inc bought a new stake in Astera Labs during the 4th quarter worth about $105,000. Sound Income Strategies LLC lifted its position in Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares in the last quarter. GAMMA Investing LLC lifted its position in Astera Labs by 55.7% during the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after buying an additional 284 shares in the last quarter. Harbour Investments Inc. lifted its position in Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after buying an additional 619 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new stake in Astera Labs during the 1st quarter worth about $48,000. 60.47% of the stock is owned by institutional investors.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 152,517 shares of the stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the transaction, the chief executive officer owned 450,001 shares in the company, valued at $76,648,670.33. This represents a 25.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the transaction, the chief operating officer owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,832,489 shares of company stock worth $264,172,396 in the last quarter. Corporate insiders own 12.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on ALAB shares. Northland Capmk cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. Jefferies Financial Group upped their target price on shares of Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Zacks Research raised shares of Astera Labs to a "strong-buy" rating in a report on Tuesday, August 12th. Susquehanna upped their target price on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. Finally, Stifel Nicolaus set a $145.00 target price on shares of Astera Labs and gave the company a "buy" rating in a report on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, Astera Labs has a consensus rating of "Moderate Buy" and a consensus price target of $142.00.

Astera Labs Stock Performance

ALAB traded up $3.25 on Friday, reaching $191.20. The company had a trading volume of 6,499,017 shares, compared to its average volume of 4,540,875. Astera Labs, Inc. has a fifty-two week low of $36.85 and a fifty-two week high of $199.47. The stock has a market cap of $31.78 billion, a P/E ratio of 341.43, a P/E/G ratio of 4.77 and a beta of 1.48. The company's fifty day moving average is $141.64 and its 200 day moving average is $98.87.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the prior year, the business earned $0.13 EPS. Astera Labs's quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.